Key result
Mechanical aortic valves yield ~2.4 deaths per 100 patient-years, led by bleeding and thromboembolism.
Why the study?
Following the first-in-human experience of Valve in Mechanical Valve (ViMech), the frequency and long-term burden of valve-related complications and reintervention after mechanical aortic valve replacement were unclear.
Meta-Analysis (n=24,960)
Effect estimate: Incidence Rate 2.39 per 100 patient-years (95% CI 1.92-2.99)
Mechanical aortic valves demonstrate low long-term reintervention rates but a steady incidence of thromboembolic and bleeding complications, highlighting a population that may eventually require emerging transcatheter valve-in-valve procedures.
Affirms mechanical AVR durability with low reintervention; extends rationale for valve-in-mechanical-valve strategies to mitigate bleeding and thromboembolism.
Aims: Following the recent first-in-human experience of Valve in Mechanical Valve (ViMech), interest has emerged in understanding how frequently such an approach might be required in clinical practice. We performed an exploratory meta-analysis to characterize the long-term burden of valve-related complications and reintervention after mechanical aortic valve replacement. Methods: Systematic literature search identified studies reporting outcomes of the five most used mechanical aortic valve models (Medtronic/ATS, St. Jude, Carbomedics, Bicarbon, On-X). Descriptive analysis and random-effects meta-analysis assessed late all-cause and valve-related mortality and complications (bleeding, thromboembolism, valve thrombosis, endocarditis, paravalvular leak, reintervention), expressed per 100 patient-years. Results: Thirty-two studies encompassing 24,960 patients undergoing mechanical valve replacement were assessed. Isolated mechanical aortic valve replacement was reported in all 32 studies (13,890 patients; 98,987 patient-years; mean follow-up 7.1 years); mean age at implantation was 57.9 years (95% CI 56.3-59.6) and 43% (38-49) were female. Pooled all-cause mortality was 2.39 per 100 patient-years (95% CI 1.92-2.99) and valve-related mortality was 0.55 (0.41-0.73) per 100 patient-years. Bleeding (0.22 [0.16-0.30]) and thromboembolic events (0.18 [0.12-0.25]) were the leading causes of valve-related death. Thromboembolic events (0.94 [0.77-1.14]) and bleeding (0.85 [0.65-1.10]) were the most frequent non-fatal complications, considerably more common than reintervention (0.36 [0.28-0.48] per 100 patient-years). All-cause mortality and complication rates were broadly similar across valve models. Conclusions: Mechanical aortic valves show excellent long-term durability with low reintervention rates. Nevertheless, valve-related complications, mainly bleeding and thromboembolism, suggest a small but clinically relevant population in whom redo surgery may carry substantial risk, providing epidemiological context for emerging Valve in Mechanical Valve strategies. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251002419, identifier CRD420251002419.
No takes yet. Share an insight, caveat, or question.
Ruiz-Ruiz et al. (2026) conducted a meta-analysis in Aortic valve disease requiring replacement (n=24,960). Mechanical aortic valve replacement was evaluated on Pooled all-cause mortality rate (per 100 patient-years) (Incidence Rate 2.39 per 100 patient-years, 95% CI 1.92-2.99). Mechanical aortic valves demonstrated excellent long-term durability with a pooled all-cause mortality rate of 2.39 per 100 patient-years and a valve-related mortality rate of 0.55 per 100 patient-years, with bleeding and thromboembolism as the leading causes of valve-related death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: